154 related articles for article (PubMed ID: 27013655)
1. Urinary Metabolite Risk Biomarkers of Lung Cancer: A Prospective Cohort Study.
Haznadar M; Cai Q; Krausz KW; Bowman ED; Margono E; Noro R; Thompson MD; Mathé EA; Munro HM; Steinwandel MD; Gonzalez FJ; Blot WJ; Harris CC
Cancer Epidemiol Biomarkers Prev; 2016 Jun; 25(6):978-86. PubMed ID: 27013655
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive urinary metabolomic profiling identifies diagnostic and prognostic markers in lung cancer.
Mathé EA; Patterson AD; Haznadar M; Manna SK; Krausz KW; Bowman ED; Shields PG; Idle JR; Smith PB; Anami K; Kazandjian DG; Hatzakis E; Gonzalez FJ; Harris CC
Cancer Res; 2014 Jun; 74(12):3259-70. PubMed ID: 24736543
[TBL] [Abstract][Full Text] [Related]
3. Urinary protein biomarkers in the early detection of lung cancer.
Nolen BM; Lomakin A; Marrangoni A; Velikokhatnaya L; Prosser D; Lokshin AE
Cancer Prev Res (Phila); 2015 Feb; 8(2):111-9. PubMed ID: 25416410
[TBL] [Abstract][Full Text] [Related]
4. Urinary Melatonin in Relation to Postmenopausal Breast Cancer Risk According to Melatonin 1 Receptor Status.
Devore EE; Warner ET; Eliassen AH; Brown SB; Beck AH; Hankinson SE; Schernhammer ES
Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):413-419. PubMed ID: 28151704
[No Abstract] [Full Text] [Related]
5. A Nomogram Derived by Combination of Demographic and Biomarker Data Improves the Noninvasive Evaluation of Patients at Risk for Bladder Cancer.
Huang S; Kou L; Furuya H; Yu C; Goodison S; Kattan MW; Garmire L; Rosser CJ
Cancer Epidemiol Biomarkers Prev; 2016 Sep; 25(9):1361-6. PubMed ID: 27383773
[TBL] [Abstract][Full Text] [Related]
6. A lung cancer risk classifier comprising genome maintenance genes measured in normal bronchial epithelial cells.
Yeo J; Crawford EL; Zhang X; Khuder S; Chen T; Levin A; Blomquist TM; Willey JC
BMC Cancer; 2017 May; 17(1):301. PubMed ID: 28464886
[TBL] [Abstract][Full Text] [Related]
7. Circulating Inflammation Markers, Risk of Lung Cancer, and Utility for Risk Stratification.
Shiels MS; Katki HA; Hildesheim A; Pfeiffer RM; Engels EA; Williams M; Kemp TJ; Caporaso NE; Pinto LA; Chaturvedi AK
J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26220734
[TBL] [Abstract][Full Text] [Related]
8. Urinary fluorescent metabolite O-aminohippuric acid is a useful biomarker for lung cancer detection.
Funai K; Honzawa K; Suzuki M; Momiki S; Asai K; Kasamatsu N; Kawase A; Shinke T; Okada H; Nishizawa S; Takamoto H
Metabolomics; 2020 Sep; 16(10):101. PubMed ID: 32940815
[TBL] [Abstract][Full Text] [Related]
9. Urinary volatile compounds as biomarkers for lung cancer.
Hanai Y; Shimono K; Matsumura K; Vachani A; Albelda S; Yamazaki K; Beauchamp GK; Oka H
Biosci Biotechnol Biochem; 2012; 76(4):679-84. PubMed ID: 22484930
[TBL] [Abstract][Full Text] [Related]
10. Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms.
Patel D; Thompson MD; Manna SK; Krausz KW; Zhang L; Nilubol N; Gonzalez FJ; Kebebew E
Clin Cancer Res; 2017 Sep; 23(17):5302-5310. PubMed ID: 28450405
[No Abstract] [Full Text] [Related]
11. Polycyclic aromatic hydrocarbon-induced oxidative stress, antioxidant capacity, and the risk of lung cancer: a pilot nested case-control study.
Eom SY; Yim DH; Moon SI; Youn JW; Kwon HJ; Oh HC; Yang JJ; Park SK; Yoo KY; Kim HS; Lee KS; Chang SH; Kim YD; Kang JW; Kim H
Anticancer Res; 2013 Aug; 33(8):3089-97. PubMed ID: 23898064
[TBL] [Abstract][Full Text] [Related]
12. Beta-cryptoxanthin and lung cancer in Shanghai, China--an examination of potential confounding with cigarette smoking using urinary cotinine as a biomarker for true tobacco exposure.
Stram DO; Yuan JM; Chan KK; Gao YT; Ross RK; Yu MC
Nutr Cancer; 2007; 57(2):123-9. PubMed ID: 17571944
[TBL] [Abstract][Full Text] [Related]
13. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
14. Elevated Levels of Urinary PGE-M Are Found in Tobacco Users and Indicate a Poor Prognosis for Oral Squamous Cell Carcinoma Patients.
Kekatpure VD; Bs N; Wang H; Zhou XK; Kandasamy C; Sunny SP; Suresh A; Milne GL; Kuriakose MA; Dannenberg AJ
Cancer Prev Res (Phila); 2016 Jun; 9(6):428-36. PubMed ID: 27045033
[TBL] [Abstract][Full Text] [Related]
15. Modified nucleosides as biomarkers for early cancer diagnose in exposed populations.
Seidel A; Seidel P; Manuwald O; Herbarth O
Environ Toxicol; 2015 Jul; 30(8):956-67. PubMed ID: 24615900
[TBL] [Abstract][Full Text] [Related]
16. Urinary nicotine metabolite excretion and lung cancer risk in a female cohort.
Ellard GA; de Waard F; Kemmeren JM
Br J Cancer; 1995 Sep; 72(3):788-91. PubMed ID: 7669596
[TBL] [Abstract][Full Text] [Related]
17. Significant correlation between urinary N(1), N(12)-diacetylspermine and tumor invasiveness in patients with clinical stage IA non-small cell lung cancer.
Takahashi Y; Horio H; Sakaguchi K; Hiramatsu K; Kawakita M
BMC Cancer; 2015 Feb; 15():65. PubMed ID: 25884987
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of urinary and serum cross-linked N-telopeptide of type I collagen (NTx) for diagnosis of bone metastasis in patients with lung cancer.
Tamiya M; Tokunaga S; Okada H; Suzuki H; Kobayashi M; Sasada S; Okamoto N; Morishita N; Matsuura Y; Miyamoto N; Hattori M; Taira K; Daga H; Takeda K; Hirashima T
Clin Lung Cancer; 2013 Jul; 14(4):364-9. PubMed ID: 23276824
[TBL] [Abstract][Full Text] [Related]
19. Urinary 8-isoprostane levels and occurrence of lung, colorectal, prostate, breast and overall cancer: Results from a large, population-based cohort study with 14 years of follow-up.
Gào X; Brenner H; Holleczek B; Cuk K; Zhang Y; Anusruti A; Xuan Y; Xu Y; Schöttker B
Free Radic Biol Med; 2018 Aug; 123():20-26. PubMed ID: 29778463
[TBL] [Abstract][Full Text] [Related]
20. Integrated ionization approach for RRLC-MS/MS-based metabonomics: finding potential biomarkers for lung cancer.
An Z; Chen Y; Zhang R; Song Y; Sun J; He J; Bai J; Dong L; Zhan Q; Abliz Z
J Proteome Res; 2010 Aug; 9(8):4071-81. PubMed ID: 20560663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
